Celularity Inc SEC filings CELU
Celularity Inc has 560 filings in SEC EDGAR's recent list, going back to Nov 5, 2018. Its latest annual report, Form 10-K, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 20, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 29, 2026 | Oct 29, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 29, 2026 | Oct 28, 2026 |
| 10-Q | Quarterly report | Oct 20, 2026 | Jun 30, 2026 |
| 10-K/A | Amended annual report | Oct 20, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 29, 2026 | Sep 29, 2026 |
| 10-Q | Quarterly report | Sep 29, 2026 | Mar 31, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 28, 2026 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Officer or director change
|
Sep 28, 2026 | Sep 18, 2026 |
| 4 | Insider transaction | Sep 25, 2026 | Sep 23, 2026 |
| 4 | Insider transaction | Sep 25, 2026 | Sep 23, 2026 |
| 4 | Insider transaction | Sep 25, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Other events
|
Sep 14, 2026 | Sep 11, 2026 |
| NT 10-Q | Filing | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 7, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Listing notice
|
Jul 29, 2026 | Jul 23, 2026 |
| 25-NSE | Delisting notice | Jul 22, 2026 | — |
| 8-K |
Current report
Material agreement, New debt, Officer or director change
|
Jun 30, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 25, 2026 | Jun 19, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 19, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 19, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 19, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 23, 2026 | — |
| 8-K |
Current report
Listing notice
|
Jun 12, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 3, 2026 | May 29, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
May 28, 2026 | May 21, 2026 |
| NT 10-Q | Filing | May 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Apr 30, 2026 | Dec 31, 2025 |
| 3 | Initial insider ownership | Apr 24, 2026 | Apr 20, 2026 |
| 3 | Initial insider ownership | Apr 24, 2026 | Apr 20, 2026 |
| 3 | Initial insider ownership | Apr 24, 2026 | Apr 20, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 22, 2026 | — |
| 8-K |
Current report
Material agreement, New debt, Change to shareholder rights, Officer or director change, Other events
|
Apr 21, 2026 | Apr 9, 2026 |
| 4 | Insider transaction | Apr 15, 2026 | Apr 13, 2026 |
| 4 | Insider transaction | Apr 15, 2026 | Apr 13, 2026 |
| 4 | Insider transaction | Apr 15, 2026 | Apr 13, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Apr 3, 2026 | — |
| NT 10-K | Filing | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 10, 2026 | Mar 6, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 5, 2026 | Feb 27, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 11, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jan 21, 2026 | Jan 16, 2026 |
| 4/A | Filing | Jan 15, 2026 | Jan 12, 2026 |
| 4/A | Filing | Jan 15, 2026 | Jan 12, 2026 |
| 4/A | Filing | Jan 15, 2026 | Jan 12, 2026 |
| 4/A | Filing | Jan 15, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 14, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 14, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 14, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 14, 2026 | Jan 12, 2026 |
| 424B3 | Prospectus | Jan 8, 2026 | — |
| EFFECT | Filing | Jan 7, 2026 | — |
| CORRESP | Letter to the SEC | Jan 5, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 5, 2026 | — |
| S-1 | Registration statement | Dec 31, 2025 | — |
| 4 | Insider transaction | Dec 30, 2025 | Dec 29, 2025 |
| 4 | Insider transaction | Dec 30, 2025 | Dec 29, 2025 |
| 4 | Insider transaction | Dec 30, 2025 | Dec 29, 2025 |
| 4 | Insider transaction | Dec 30, 2025 | Dec 29, 2025 |
| 424B3 | Prospectus | Dec 30, 2025 | — |
| EFFECT | Filing | Dec 29, 2025 | — |
| CORRESP | Letter to the SEC | Dec 23, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Dec 23, 2025 | Dec 19, 2025 |
| UPLOAD | Letter from the SEC | Dec 23, 2025 | — |
| 4 | Insider transaction | Dec 22, 2025 | Dec 19, 2025 |
| 4 | Insider transaction | Dec 22, 2025 | Dec 19, 2025 |
| 4 | Insider transaction | Dec 22, 2025 | Dec 19, 2025 |
| S-1 | Registration statement | Dec 19, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Dec 19, 2025 | Dec 19, 2025 |
| 8-K |
Current report
Other events
|
Dec 5, 2025 | Dec 5, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| S-8 | Employee stock plan registration | Nov 7, 2025 | — |
| DEFA14A | Additional proxy material | Nov 7, 2025 | — |
| ARS | Annual report to shareholders | Nov 7, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Nov 7, 2025 | Nov 7, 2025 |
| D | Filing | Nov 3, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
|
Oct 28, 2025 | Oct 24, 2025 |
| 8-K |
Current report
Other events
|
Sep 3, 2025 | Sep 2, 2025 |
| 10-Q | Quarterly report | Aug 29, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | Aug 29, 2025 | Mar 31, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 27, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Aug 18, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 12, 2025 | Aug 5, 2025 |
| D | Filing | Aug 5, 2025 | — |
| D | Filing | Aug 5, 2025 | — |
| D | Filing | Aug 5, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 1, 2025 | Jul 21, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 30, 2025 | Jul 14, 2025 |
| 8-K/A | Amended current report | Jul 29, 2025 | Feb 12, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 28, 2025 | — |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 22, 2025 | Jun 23, 2025 |
| 3 | Initial insider ownership | Jul 16, 2025 | Jun 10, 2025 |
| 3 | Initial insider ownership | Jul 10, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 10, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 6, 2025 | Jun 5, 2025 |
| 4/A | Filing | Jun 4, 2025 | Apr 13, 2025 |
| 10-K/A | Amended annual report | May 21, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 20, 2025 | May 20, 2025 |
| 8-K |
Current report
Officer or director change
|
May 16, 2025 | May 14, 2025 |
| 8-K |
Current report
Results of operations
|
May 9, 2025 | May 9, 2025 |
| 10-K | Annual report | May 8, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
May 1, 2025 | Apr 30, 2025 |
| 8-K |
Current report
Listing notice
|
Apr 23, 2025 | Apr 16, 2025 |
| 4 | Insider transaction | Apr 15, 2025 | Apr 13, 2025 |
| 4 | Insider transaction | Apr 15, 2025 | Apr 13, 2025 |
| 4 | Insider transaction | Apr 15, 2025 | Apr 13, 2025 |
| 4 | Insider transaction | Apr 15, 2025 | Apr 13, 2025 |
| NT 10-K | Filing | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 21, 2025 | Mar 17, 2025 |
| RW | Filing | Mar 10, 2025 | — |
| 4/A | Filing | Mar 3, 2025 | Dec 19, 2024 |
| 8-K |
Current report
Other events
|
Feb 24, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 17, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 17, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 17, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 18, 2025 | Feb 12, 2025 |
| EFFECT | Filing | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 13, 2025 | — |
| CORRESP | Letter to the SEC | Feb 13, 2025 | — |
| FWP | Free writing prospectus | Feb 13, 2025 | — |
| S-1/A | Amended registration statement | Feb 13, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2025 | — |
| S-1 | Registration statement | Jan 30, 2025 | — |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 28, 2025 | — |
| 8-K |
Current report
Material agreement
|
Jan 27, 2025 | Jan 24, 2025 |
| 8-K |
Current report
Agreement ended
|
Jan 24, 2025 | Jan 23, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Dec 19, 2024 |
| 4 | Insider transaction | Jan 6, 2025 | Dec 19, 2024 |
| 4 | Insider transaction | Jan 6, 2025 | Dec 19, 2024 |
| 4 | Insider transaction | Jan 6, 2025 | Dec 19, 2024 |
| 4 | Insider transaction | Jan 6, 2025 | Dec 19, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 3, 2025 | Dec 27, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Dec 20, 2024 | Dec 19, 2024 |
| 3 | Initial insider ownership | Dec 19, 2024 | Jul 15, 2024 |
| 4 | Insider transaction | Dec 19, 2024 | Jul 15, 2024 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 19, 2024 | — |
| 10-Q | Quarterly report | Dec 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 2, 2024 | Nov 25, 2024 |
| 8-K |
Current report
Listing notice
|
Nov 29, 2024 | Nov 21, 2024 |
| DEF 14A | Proxy statement | Nov 19, 2024 | Oct 19, 2024 |
| NT 10-Q | Filing | Nov 15, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Nov 8, 2024 | Nov 8, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 7, 2024 | Nov 7, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 25, 2024 | Oct 22, 2024 |
| 8-K |
Current report
Listing notice
|
Oct 21, 2024 | Oct 18, 2024 |
| 10-Q | Quarterly report | Oct 16, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 16, 2024 | Oct 9, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 13, 2024 | Jul 24, 2024 |
| 4 | Insider transaction | Aug 28, 2024 | Aug 27, 2024 |
| 3 | Initial insider ownership | Aug 28, 2024 | Aug 27, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Aug 28, 2024 | Aug 27, 2024 |
| 8-K |
Current report
Listing notice
|
Aug 23, 2024 | Aug 22, 2024 |
| NT 10-Q | Filing | Aug 16, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Auditor change, Officer or director change
|
Aug 5, 2024 | Jul 31, 2024 |
| 10-K | Annual report | Jul 30, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Listing notice
|
May 24, 2024 | May 21, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 21, 2024 | May 21, 2024 |
| NT 10-Q | Filing | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Listing notice
|
Apr 22, 2024 | Apr 17, 2024 |
| 4 | Insider transaction | Apr 16, 2024 | Apr 13, 2024 |
| 4 | Insider transaction | Apr 16, 2024 | Apr 13, 2024 |
| 4 | Insider transaction | Apr 16, 2024 | Apr 13, 2024 |
| 4 | Insider transaction | Apr 16, 2024 | Apr 13, 2024 |
| 4 | Insider transaction | Apr 16, 2024 | Apr 13, 2024 |
| NT 10-K | Filing | Apr 1, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 15, 2024 | Mar 13, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 15, 2024 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Change to shareholder rights
|
Mar 15, 2024 | Mar 13, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Feb 26, 2024 | Feb 22, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 22, 2024 | Feb 16, 2024 |
| 4 | Insider transaction | Feb 21, 2024 | Feb 16, 2024 |
| 4 | Insider transaction | Feb 21, 2024 | Feb 16, 2024 |
| 4 | Insider transaction | Feb 21, 2024 | Feb 16, 2024 |
| 4 | Insider transaction | Feb 21, 2024 | Feb 16, 2024 |
| 4 | Insider transaction | Feb 21, 2024 | Feb 16, 2024 |
| 4 | Insider transaction | Feb 21, 2024 | Feb 16, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 12, 2024 | Feb 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 8, 2024 | — |
| DEF 14A | Proxy statement | Feb 2, 2024 | Feb 2, 2024 |
| PRE 14A | Preliminary proxy statement | Jan 23, 2024 | Jan 23, 2024 |
| 4 | Insider transaction | Jan 17, 2024 | Jan 12, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Jan 17, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Jan 17, 2024 | Jan 12, 2024 |
| 8-K |
Current report
Results of operations
|
Jan 9, 2024 | Jan 3, 2024 |
| 10-Q | Quarterly report | Jan 3, 2024 | Sep 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 29, 2023 | Dec 24, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 24, 2023 | Nov 21, 2023 |
| NT 10-Q | Filing | Nov 14, 2023 | Sep 30, 2023 |
| 4 | Insider transaction | Oct 16, 2023 | Aug 31, 2023 |
| 3 | Initial insider ownership | Oct 16, 2023 | Aug 31, 2023 |
| 4 | Insider transaction | Oct 10, 2023 | Sep 29, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CELU (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Florham Park, NJ
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1752828
- Former names
- GX Acquisition Corp. (until Jul 19, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.